Fortis Healthcare Limited (BOM:532843)
India · Delayed Price · Currency is INR 916.90
-11.30 (-1.22%)
At close: Feb 13, 2026
Fortis Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 7,742 | 5,989 | 5,887 | 5,551 | -1,098 |
Depreciation & Amortization | 3,746 | 3,321 | 3,053 | 2,854 | 2,721 |
Other Amortization | 109.96 | 103.88 | 103.88 | 154.92 | 184.61 |
Loss (Gain) From Sale of Assets | -269.91 | -98.3 | -169.08 | -116.12 | -17.69 |
Asset Writedown & Restructuring Costs | 393.78 | - | - | - | - |
Loss (Gain) From Sale of Investments | 740.87 | -92.71 | -743.5 | -3,061 | - |
Loss (Gain) on Equity Investments | -115.23 | -95.1 | -218.39 | -241.47 | -475.59 |
Stock-Based Compensation | - | - | - | - | -9.43 |
Provision & Write-off of Bad Debts | 618.05 | 396.21 | 463.32 | 382.1 | 402.95 |
Other Operating Activities | 2,386 | 1,289 | 89.5 | 3,242 | 3,273 |
Change in Accounts Receivable | -2,199 | -878.83 | -1,233 | -846.39 | 9.74 |
Change in Inventory | -86.41 | 138.92 | -19.96 | -382.21 | 14.16 |
Change in Accounts Payable | 1,044 | 519.41 | 1,042 | 1,383 | -284.35 |
Change in Other Net Operating Assets | 138.05 | 417.08 | -33.65 | -256.72 | 133.57 |
Operating Cash Flow | 14,239 | 11,001 | 8,222 | 8,654 | 4,855 |
Operating Cash Flow Growth | 29.44% | 33.79% | -4.99% | 78.25% | 183.01% |
Capital Expenditures | -8,469 | -9,425 | -4,472 | -2,155 | -2,185 |
Sale of Property, Plant & Equipment | 400.97 | 2,767 | 222.86 | 1,002 | 69.79 |
Cash Acquisitions | -278.64 | -1,150 | -263.83 | -3,250 | -10.5 |
Investment in Securities | -43.28 | -1,396 | 492.66 | -1,127 | 78.64 |
Other Investing Activities | 596.54 | 340.47 | 283.66 | 380.91 | 696.16 |
Investing Cash Flow | -7,794 | -8,864 | -3,737 | -5,144 | -1,351 |
Short-Term Debt Issued | 3.96 | - | - | - | - |
Long-Term Debt Issued | 15,609 | 6,119 | 2,401 | 3,064 | 3,355 |
Total Debt Issued | 15,613 | 6,119 | 2,401 | 3,064 | 3,355 |
Short-Term Debt Repaid | - | -38.58 | -860.99 | -444.91 | -502.84 |
Long-Term Debt Repaid | -2,505 | -4,785 | -4,796 | -6,322 | -2,595 |
Total Debt Repaid | -2,505 | -4,823 | -5,657 | -6,767 | -3,098 |
Net Debt Issued (Repaid) | 13,108 | 1,296 | -3,256 | -3,703 | 256.67 |
Common Dividends Paid | -1,089 | -860.32 | -159.77 | - | - |
Other Financing Activities | -19,158 | -1,300 | -1,297 | -1,470 | -1,686 |
Financing Cash Flow | -7,139 | -864.58 | -4,712 | -5,173 | -1,429 |
Foreign Exchange Rate Adjustments | -4.56 | -27.52 | 12.42 | 0.55 | 45.47 |
Miscellaneous Cash Flow Adjustments | - | - | -0.22 | 137.15 | - |
Net Cash Flow | -697.58 | 1,245 | -214.55 | -1,525 | 2,120 |
Free Cash Flow | 5,770 | 1,576 | 3,750 | 6,499 | 2,670 |
Free Cash Flow Growth | 266.04% | -57.97% | -42.30% | 143.42% | 1605.10% |
Free Cash Flow Margin | 7.41% | 2.28% | 5.96% | 11.37% | 6.63% |
Free Cash Flow Per Share | 7.64 | 2.09 | 4.97 | 8.61 | 3.54 |
Cash Interest Paid | 1,381 | 1,300 | 1,297 | 1,470 | 1,686 |
Cash Income Tax Paid | 1,097 | 2,218 | 2,742 | 2,114 | -474.56 |
Levered Free Cash Flow | -15,063 | 18,819 | 1,855 | 5,310 | -11,379 |
Unlevered Free Cash Flow | -14,175 | 19,404 | 2,472 | 6,056 | -10,500 |
Change in Working Capital | -1,104 | 196.58 | -244.04 | -102.27 | -126.89 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.